Kulasekararaj, A., Rao, K., Pearce, R., Lee, J., Wilson, M., Khan, A., Protheroe, R., Krishnamurthy, P., Wynn, R., Amrolia, P., Potter, V. (2025). Excellent long-term outcomes after alemtuzumab-based hematopoietic cell transplantation (HCT) for severe aplastic anemia (SAA) and inherited bone marrow failure syndromes (IBMF): A 25-year British society of blood and marrow transplantation and cellular therapy (BSBMTCT) retrospective analysis of 1754 patients from the United Kingdom (UK). Blood. https://doi.org/10.1182/blood-2025-984